SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-002642
Filing Date
2013-05-14
Accepted
2013-05-14 06:00:42
Documents
12
Period of Report
2013-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50631689.htm 8-K 20491
2 EXHIBIT 99.1 a50631689_ex991.htm EX-99.1 42553
3 EXHIBIT 99.2 a50631689_ex992.htm EX-99.2 17527
4 SLIDE 1 slide1.jpg GRAPHIC 56248
5 SLIDE 2 slide2.jpg GRAPHIC 177474
6 SLIDE 3 slide3.jpg GRAPHIC 48431
7 SLIDE 4 slide4.jpg GRAPHIC 106509
8 SLIDE 5 slide5.jpg GRAPHIC 83370
9 SLIDE 6 slide6.jpg GRAPHIC 90576
10 SLIDE 7 slide7.jpg GRAPHIC 71859
11 SLIDE 8 slide8.jpg GRAPHIC 73600
12 SLIDE 9 slide9.jpg GRAPHIC 74769
  Complete submission text file 0001157523-13-002642.txt   1161822
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 13839155
SIC: 2834 Pharmaceutical Preparations